N2 Biomedical, a provider of coating and surface treatment solutions to the medical device industry, is pleased to announce that Keith Edwards has been appointed CEO. Edwards will assume leadership of all aspects of the organization and will oversee the implementation of N2’s growth strategy.
 
Edwards brings a wealth of expertise to this role, with more than 20 years of experience within the medical device industry and a particular focus on the orthopedic market. Most recently, he served as SVP and general manager of Hamilton Thorne, Ltd., and prior to this role, served as president and CEO of Biocoat Inc. Preceding his role at Biocoat, Edwards served in numerous senior management positions within Biomet Orthopedics during his five-year tenure. He is a graduate of Union College and attended New York Medical College.
 
“Keith’s broad experience in the orthopedic space makes him an ideal fit for his role at N2, and we are thrilled to have him join at this point in N2’s evolution,” said Trevor Wahlbrink, a Partner at Ampersand Capital Partners and member of the Board of Directors. “He has a proven ability to lead innovative service companies and has personally overseen thoughtful growth and expansion within this market. Under Keith’s leadership, N2 is well-positioned to continue to bring its innovative coating and surface treatment technologies to the medical device market.”
 
Edwards commented, “N2 Biomedical has an excellent surface treatment offering, superb culture, and a team committed to excellence and each client’s success. I look forward to advancing organic growth at N2 and supporting our dedicated team.”